
Global incidence and prevalence of idiopathic pulmonary fibrosis
Jul 7, 2021 · Based on the countries included in our analysis, we estimated the adjusted incidence and prevalence of IPF to be in the range of 0.09-1.30 and 0.33-4.51 per 10,000 persons, respectively. According to these prevalence estimates, IPF remains a rare disease.
Idiopathic pulmonary fibrosis: Current and future treatment
Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease characterized by fibrosis, inflammation, and destruction of lung architecture. 1 , 2 , 3 Damage to the alveolar epithelium and abnormal wound repair are theorized to be key factors in the development of this disease.
Global incidence and prevalence of idiopathic pulmonary fibrosis
Jul 7, 2021 · Based on the countries included in our analysis, we estimated the adjusted incidence and prevalence of IPF to be in the range of 0.09–1.30 and 0.33–4.51 per 10,000 persons, respectively. According to these prevalence estimates, IPF remains a rare disease.
Results - International Powerlifting Federation IPF
2021. World Open Powerlifting Championships 2021; World Masters Powerlifting Championships 2021; World Sub-Junior and Junior Powerlifting Championships 2021; World University Powerlifting Cup 2021; World Classic Powerlifting Championships 2021; World Open, Sub-Juniors, Juniors, Masters Classic & Equipped Bench Press Championships 2021; 2019
Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
Jul 1, 2021 · In this issue of CHEST, Petnak et al 11 have synthesized data from eight randomized controlled trials and 18 real-world studies in a systematic review and meta-analysis to evaluate the impact of nintedanib and pirfenidone on both death and acute exacerbation in IPF.
Real-World Data on the Course of Idiopathic Pulmonary Fibrosis
Oct 16, 2024 · Delayed IPF diagnosis often results in significant lung function impairment, impacting patient outcomes and increasing hospitalization rates. Antifibrotic therapies, nintedanib and pirfenidone,...
Idiopathic Pulmonary Fibrosis Mortality by Industry and ...
Mar 6, 2025 · Idiopathic pulmonary fibrosis (IPF), a progressive lung disease characterized by scarring and worsening lung function, has a poor prognosis. A recent systematic review estimated that 21% of IPF deaths might be attributable to occupational exposures.
Epidemiology of idiopathic pulmonary fibrosis in central and …
Mar 10, 2025 · Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive disease of unknown origin. ... We identified adults ≥ 30 years old diagnosed with IPF (by ICD-9/10 coding) between 2013 to 2021 from two health systems (UPMC Health System and Penn State Health) participating in the PaTH Clinical Research Network. We extracted information on ...
Genetic insights into idiopathic pulmonary fibrosis: a multi …
Mar 16, 2025 · Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease (ILD) characterized by scarring of lung tissue, which progressively impairs lung function, eventually leading to respiratory failure and death [].Epidemiological data indicate that the incidence of IPF ranges from 0.09 to 1.30 per 10,000 people, with prevalence between …
Diagnosis accuracy of machine learning for idiopathic pulmonary ...
1 day ago · Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease of unknown origin, marked by progressive lung constriction. A study published in 2021 indicated that the incidence rate ranged from 0.9 to 13.0 per 100,000 people, and the prevalence rate varied from 3.3 to 45.1 per 100,000 people [].IPF, as the most prevalent idiopathic interstitial pneumonia (IIP), is linked to the ...